iZafe Group AB Series B
Research iZafe Group AB Series B (IZAFE-B) on Bullrun: market cap SEK 134.99M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerIZAFE-B
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencySEK
- Market capSEK 134.99M
- Financial periodQ1 2026
- RevenueSEK 2.42M
- Net income-SEK 6.48M
- Free cash flow-SEK 4.65M
- Gross margin69.5%
Valuation Snapshot
latest market cap is SEK 134.99M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | SEK 5.99M | -SEK 16.68M | -SEK 14.56M | 40.1% | -0.04 | SEK 1.67M | SEK 63.00K | SEK 11.69M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-05 | SEK 134.99M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 SEK.
About iZafe Group AB Series B
iZafe Group AB (publ), a medical technology company, develops and markets medical and digital security solutions in Sweden and internationally. It offers Dosell, an automated medication dispenser for medication at home; and Pilloxa, an app for clinical studies, as well as to engage and involve patients. The company was formerly known as MediRätt AB (publ) and changed its name to iZafe Group AB (publ) in May 2019. iZafe Group AB (publ) was incorporated in 2008 and is headquartered in Stockholm, Sweden.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is iZafe Group AB Series B's market cap?
iZafe Group AB Series B's market capitalization is SEK 134.99M.
What does iZafe Group AB Series B do?
iZafe Group AB (publ), a medical technology company, develops and markets medical and digital security solutions in Sweden and internationally. It offers Dosell, an automated medication dispenser for medication at home; and Pilloxa, an app for clinical studies, as well as to engage and involve patients. The company was formerly known as MediRätt AB (publ) and changed its name to iZafe Group AB (publ) in May 2019. iZafe Group AB (publ) was incorporated in 2008 and is headquartered in Stockholm, Sweden.